BG104654A - Method for treatment of chronic obstructive pulmonary disease (copd) - Google Patents

Method for treatment of chronic obstructive pulmonary disease (copd)

Info

Publication number: BG104654A
Authority: BG; Bulgaria
Prior art keywords: copd; treatment; pulmonary disease; chronic obstructive; obstructive pulmonary
Prior art date: 1998-01-07

Application number

BG104654A

Other languages

Bulgarian (bg)

English (en)

Inventor

Siegfried Christensen

Theodore Torphy

Original Assignee

Smithkline Beecham Corporation

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-01-07

Filing date

2000-08-01

Publication date

2001-04-30

2000-08-01 Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation

2001-04-30 Publication of BG104654A publication Critical patent/BG104654A/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pulmonology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Indole Compounds (AREA)

BG104654A 1998-01-07 2000-08-01 Method for treatment of chronic obstructive pulmonary disease (copd) BG104654A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US7071898P	1998-01-07	1998-01-07
US10690898P	1998-10-28	1998-10-28
PCT/US1999/000214 WO1999034798A1 (en)	1998-01-07	1999-01-06	Method for treating copd

Publications (1)

Publication Number	Publication Date
BG104654A true BG104654A (en)	2001-04-30

Family

ID=26751429

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG104654A BG104654A (en)	1998-01-07	2000-08-01	Method for treatment of chronic obstructive pulmonary disease (copd)

Country Status (33)

Country	Link
US (1)	US6369108B1 (tr)
EP (1)	EP1051172B1 (tr)
JP (1)	JP2003522095A (tr)
KR (1)	KR100555824B1 (tr)
CN (1)	CN1291891A (tr)
AP (1)	AP2000001859A0 (tr)
AR (1)	AR014411A1 (tr)
AT (1)	ATE285234T1 (tr)
AU (1)	AU752497B2 (tr)
BG (1)	BG104654A (tr)
BR (1)	BR9906803A (tr)
CA (1)	CA2317720A1 (tr)
DE (1)	DE69922786T2 (tr)
DZ (1)	DZ2703A1 (tr)
EA (1)	EA006382B1 (tr)
EG (1)	EG23945A (tr)
ES (1)	ES2234234T3 (tr)
HU (1)	HUP0100888A3 (tr)
ID (1)	ID26164A (tr)
IL (1)	IL137104A0 (tr)
MA (1)	MA26592A1 (tr)
MY (1)	MY133014A (tr)
NO (1)	NO20003481L (tr)
NZ (1)	NZ505521A (tr)
OA (1)	OA11443A (tr)
PE (1)	PE20000231A1 (tr)
PL (1)	PL341667A1 (tr)
PT (1)	PT1051172E (tr)
SI (1)	SI1051172T1 (tr)
SK (1)	SK285149B6 (tr)
TR (1)	TR200001819T2 (tr)
UY (1)	UY25338A1 (tr)
WO (1)	WO1999034798A1 (tr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DZ3019A1 (fr)	1999-03-01	2005-05-20	Smithkline Beecham Corp	Utilisation d'un inhibiteur de pde4 dans la préparation d'un médicament contre la copd.
AR024076A1 (es) *	1999-05-25	2002-09-04	Smithkline Beecham Corp	Sales de cis-[4-ciano-4-(3-ciclopentiloxi-4-metoxifenil) ciclohexan-1-carboxilato]
CZ2002460A3 (cs) *	1999-08-10	2002-06-12	Smithkline Beecham Corporation	1,4-Substituované 4,4-diarylcyklohexany
WO2001043692A2 (en) *	1999-12-15	2001-06-21	Smithkline Beecham Corporation	SALTS OF Cis-4-CYANO-4-[3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]CYCLOHEXANE-1-CARBOXYLIC ACID
AU4215801A (en)	2000-03-16	2001-09-24	Inflazyme Pharm Ltd	Benzylated pde4 inhibitors
DE10245153A1 (de) *	2002-09-27	2004-04-15	Infineon Technologies Ag	Integrierter Feldeffekttransistor mit zwei Steuerbereichen, Verwendung dieses Feldeffekttranistors und Herstellungsverfahren
ES2382876T3 (es)	2005-05-31	2012-06-14	Pfizer, Inc.	Compuestos de ariloxi-N-biciclometil-acetamida sustituidos como antagonistas de VR1
DK2164825T3 (da)	2007-06-05	2014-07-14	Sanofi Sa	Di(hetero)arylcyclohexanderivater, deres fremstilling, deres anvendelse og terapeutiske præparater, der omfatter disse

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP3199380B2 (ja) *	1992-04-02	2001-08-20	スミスクライン・ビーチャム・コーポレイション	化合物
NZ251092A (en) *	1992-04-02	1996-12-20	Smithkline Beecham Corp	4-cyano-cyclohexane derivatives; medicaments; used in treating asthma
GB9525262D0 (en) *	1995-12-11	1996-02-07	Bayer Ag	Heterocyclylcarbonyl substituted benzofuranyl-ureas

1998
- 1998-12-31 UY UY25338A patent/UY25338A1/es not_active Application Discontinuation
1999
- 1999-01-04 MA MA25416A patent/MA26592A1/fr unknown
- 1999-01-05 MY MYPI99000027A patent/MY133014A/en unknown
- 1999-01-06 ID IDW20001314A patent/ID26164A/id unknown
- 1999-01-06 US US09/582,739 patent/US6369108B1/en not_active Expired - Fee Related
- 1999-01-06 EP EP99901337A patent/EP1051172B1/en not_active Expired - Lifetime
- 1999-01-06 NZ NZ505521A patent/NZ505521A/xx unknown
- 1999-01-06 TR TR2000/01819T patent/TR200001819T2/tr unknown
- 1999-01-06 AP APAP/P/2000/001859A patent/AP2000001859A0/en unknown
- 1999-01-06 AU AU21060/99A patent/AU752497B2/en not_active Ceased
- 1999-01-06 JP JP2000527247A patent/JP2003522095A/ja active Pending
- 1999-01-06 BR BR9906803-6A patent/BR9906803A/pt not_active Application Discontinuation
- 1999-01-06 PL PL99341667A patent/PL341667A1/xx not_active IP Right Cessation
- 1999-01-06 ES ES99901337T patent/ES2234234T3/es not_active Expired - Lifetime
- 1999-01-06 AT AT99901337T patent/ATE285234T1/de not_active IP Right Cessation
- 1999-01-06 HU HU0100888A patent/HUP0100888A3/hu unknown
- 1999-01-06 EG EG1499A patent/EG23945A/xx active
- 1999-01-06 IL IL13710499A patent/IL137104A0/xx not_active IP Right Cessation
- 1999-01-06 CN CN99803407A patent/CN1291891A/zh active Pending
- 1999-01-06 KR KR1020007007487A patent/KR100555824B1/ko not_active Expired - Fee Related
- 1999-01-06 PE PE1999000011A patent/PE20000231A1/es not_active Application Discontinuation
- 1999-01-06 SI SI9930757T patent/SI1051172T1/xx unknown
- 1999-01-06 DZ DZ990004A patent/DZ2703A1/xx active
- 1999-01-06 CA CA002317720A patent/CA2317720A1/en not_active Abandoned
- 1999-01-06 PT PT99901337T patent/PT1051172E/pt unknown
- 1999-01-06 DE DE69922786T patent/DE69922786T2/de not_active Expired - Fee Related
- 1999-01-06 EA EA200000740A patent/EA006382B1/ru not_active IP Right Cessation
- 1999-01-06 WO PCT/US1999/000214 patent/WO1999034798A1/en not_active Ceased
- 1999-01-06 SK SK1023-2000A patent/SK285149B6/sk not_active IP Right Cessation
- 1999-01-08 AR ARP990100057A patent/AR014411A1/es unknown
2000
- 2000-07-06 NO NO20003481A patent/NO20003481L/no not_active Application Discontinuation
- 2000-07-07 OA OA1200000199A patent/OA11443A/en unknown
- 2000-08-01 BG BG104654A patent/BG104654A/xx unknown

Also Published As

Publication number	Publication date
KR20010033909A (ko)	2001-04-25
SI1051172T1 (en)	2005-06-30
BR9906803A (pt)	2002-05-28
PT1051172E (pt)	2005-03-31
AP2000001859A0 (en)	2000-09-30
AU752497B2 (en)	2002-09-19
DE69922786D1 (de)	2005-01-27
NZ505521A (en)	2004-02-27
DE69922786T2 (de)	2005-06-23
EP1051172B1 (en)	2004-12-22
UY25338A1 (es)	2001-08-27
NO20003481L (no)	2000-08-25
DZ2703A1 (fr)	2003-09-01
MA26592A1 (fr)	2004-12-20
ES2234234T3 (es)	2005-06-16
JP2003522095A (ja)	2003-07-22
NO20003481D0 (no)	2000-07-06
WO1999034798A1 (en)	1999-07-15
PE20000231A1 (es)	2000-03-24
OA11443A (en)	2004-04-28
AR014411A1 (es)	2001-02-28
HK1033551A1 (en)	2001-09-07
HUP0100888A2 (hu)	2001-08-28
EG23945A (en)	2008-01-22
MY133014A (en)	2007-10-31
EA006382B1 (ru)	2005-12-29
ID26164A (id)	2000-11-30
SK10232000A3 (sk)	2001-01-18
US6369108B1 (en)	2002-04-09
KR100555824B1 (ko)	2006-03-03
EP1051172A4 (en)	2002-08-14
SK285149B6 (sk)	2006-07-07
PL341667A1 (en)	2001-04-23
EA200000740A1 (ru)	2001-02-26
TR200001819T2 (tr)	2000-11-21
AU2106099A (en)	1999-07-26
CA2317720A1 (en)	1999-07-15
ATE285234T1 (de)	2005-01-15
CN1291891A (zh)	2001-04-18
IL137104A0 (en)	2001-06-14
HUP0100888A3 (en)	2003-07-28
EP1051172A2 (en)	2000-11-15

Similar Documents

Publication	Publication Date	Title
NZ330216A (en)	2000-09-29	Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and use in treatment of atherosclerosis
NO971520L (no)	1997-04-03	Fremgangsmåte for hemming av tilstander forbundet med neuropeptid Y
EP0842661A3 (en)	1998-09-02	Atherosclerosis treatment
WO2001081312A3 (en)	2002-08-08	Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore
MX9803809A (es)	1998-09-30	Inhibidores de hidroxamato de bifenilo de metaloproteinasas de matriz.
CA2283399A1 (en)	1998-09-24	Pyridazinones as inhibitors of cyclooxygenase-2
AU7579194A (en)	1995-05-04	Methods for inhibiting angiogenisis and angiogenic diseases
IL126137A0 (en)	1999-05-09	New benzofuranone derivatives and a method for producing them
NO20000093D0 (no)	2000-01-07	(+)-Norcisaprid nyttig for 5-HT3 og 5-HT4-medierte forstyrrelser
BG104654A (en)	2001-04-30	Method for treatment of chronic obstructive pulmonary disease (copd)
IL126235A0 (en)	1999-05-09	Compounds with growth hormone releasing properties
PL323235A1 (en)	1998-03-16	Derivatives of piperazine as neurokinin antagonists
ATE180669T1 (de)	1999-06-15	Verwendung von pregnanderivaten zur behandlung von tumoren
BG105953A (bg)	2002-05-31	Метод за лечение на хронична обструктивна белодробна болест
AP2002002496A0 (en)	2002-06-30	Method and compositions for treating pulmonary diseases.
NZ502366A (en)	2004-12-24	Aminoethylphenoxyacetic acid derivatives and drugs for pain remission and calculi removal promotion in urinary lithiasis
WO2003053352A3 (en)	2003-11-20	Therapeutic compounds for treating dyslipidemic conditions
SE9702716D0 (sv)	1997-07-15	Substituted phenylazacycloalkanes in the treatment of cognitive disorders
CA2301590A1 (en)	1999-03-25	2-aminopyridines as inhibitors of cyclooxygenase-2
GR3036241T3 (en)	2001-10-31	METHOD OF TREATMENT OF CHRONIC PROSTATITIS WITH 17-g(b)-N-MONOSUBSTITUTED-CARBAMOYL-4-AZA-5-g(a)-ANDROST-1-EN-3-ONES.
IL156768A0 (en)	2004-02-08	Process for preparing (+/-) trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidine
EP0378146A3 (en)	1991-04-24	Polyamine derivatives as antineoplastic agents
IL154915A0 (en)	2003-10-31	Method for producing chiral compounds
MX9604692A (es)	1998-04-30	Derivados de quinoxalina para el tratamiento de tinnitus.
AU2178099A (en)	1999-08-09	Azetidinecarboxamide derivatives for treating cns disorders